The global Healthcare-associated Infectious Disease Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Healthcare-associated Infectious Disease Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare-associated Infectious Disease Diagnostics.

Report Scope

The Healthcare-associated Infectious Disease Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Healthcare-associated Infectious Disease Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Healthcare-associated Infectious Disease Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Healthcare-associated Infectious Disease Diagnostics Market Report

Report Metric	Details
Report Name	Healthcare-associated Infectious Disease Diagnostics Market
CAGR	5%
Segment by Type	Urinary Tract Infections Surgical Site Infections Hospital-acquired Pneumonia BloodStream Infections Gastrointestinal Infections
Segment by Application	Hospitals Clinics ASCs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Accelerate Diagnostics, BD, bioMrieux, Bio-Rad, DiaSorin Molecular, F. Hoffmann-La Roche, Luminex, Meridian Bioscience, OpGen, QIAGEN, Quidel, Thermo Fisher Scientific, Trinity Biotech, Danaher
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Healthcare-associated Infectious Disease Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Healthcare-associated Infectious Disease Diagnostics Market report?

Ans: The main players in the Healthcare-associated Infectious Disease Diagnostics Market are Abbott, Accelerate Diagnostics, BD, bioMrieux, Bio-Rad, DiaSorin Molecular, F. Hoffmann-La Roche, Luminex, Meridian Bioscience, OpGen, QIAGEN, Quidel, Thermo Fisher Scientific, Trinity Biotech, Danaher

What are the Application segmentation covered in the Healthcare-associated Infectious Disease Diagnostics Market report?

Ans: The Applications covered in the Healthcare-associated Infectious Disease Diagnostics Market report are Hospitals, Clinics, ASCs

What are the Type segmentation covered in the Healthcare-associated Infectious Disease Diagnostics Market report?

Ans: The Types covered in the Healthcare-associated Infectious Disease Diagnostics Market report are Urinary Tract Infections, Surgical Site Infections, Hospital-acquired Pneumonia, BloodStream Infections, Gastrointestinal Infections

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Urinary Tract Infections

1.2.3 Surgical Site Infections

1.2.4 Hospital-acquired Pneumonia

1.2.5 BloodStream Infections

1.2.6 Gastrointestinal Infections

1.3 Market by Application

1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 ASCs

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2019-2030)

2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Region

2.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Healthcare-associated Infectious Disease Diagnostics Market Dynamics

2.3.1 Healthcare-associated Infectious Disease Diagnostics Industry Trends

2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers

2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges

2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue

3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue

3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio

3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2023

3.5 Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Area Served

3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service

3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Type

4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2025-2030)

5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application

5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2019-2030)

6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024)

6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2019-2030)

7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024)

7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2019-2030)

9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Detail

11.1.2 Abbott Business Overview

11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction

11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.1.5 Abbott Recent Development

11.2 Accelerate Diagnostics

11.2.1 Accelerate Diagnostics Company Detail

11.2.2 Accelerate Diagnostics Business Overview

11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction

11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.2.5 Accelerate Diagnostics Recent Development

11.3 BD

11.3.1 BD Company Detail

11.3.2 BD Business Overview

11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction

11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.3.5 BD Recent Development

11.4 bioMrieux

11.4.1 bioMrieux Company Detail

11.4.2 bioMrieux Business Overview

11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction

11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.4.5 bioMrieux Recent Development

11.5 Bio-Rad

11.5.1 Bio-Rad Company Detail

11.5.2 Bio-Rad Business Overview

11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction

11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.5.5 Bio-Rad Recent Development

11.6 DiaSorin Molecular

11.6.1 DiaSorin Molecular Company Detail

11.6.2 DiaSorin Molecular Business Overview

11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction

11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.6.5 DiaSorin Molecular Recent Development

11.7 F. Hoffmann-La Roche

11.7.1 F. Hoffmann-La Roche Company Detail

11.7.2 F. Hoffmann-La Roche Business Overview

11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction

11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.7.5 F. Hoffmann-La Roche Recent Development

11.8 Luminex

11.8.1 Luminex Company Detail

11.8.2 Luminex Business Overview

11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction

11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.8.5 Luminex Recent Development

11.9 Meridian Bioscience

11.9.1 Meridian Bioscience Company Detail

11.9.2 Meridian Bioscience Business Overview

11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction

11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.9.5 Meridian Bioscience Recent Development

11.10 OpGen

11.10.1 OpGen Company Detail

11.10.2 OpGen Business Overview

11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction

11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.10.5 OpGen Recent Development

11.11 QIAGEN

11.11.1 QIAGEN Company Detail

11.11.2 QIAGEN Business Overview

11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction

11.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.11.5 QIAGEN Recent Development

11.12 Quidel

11.12.1 Quidel Company Detail

11.12.2 Quidel Business Overview

11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction

11.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.12.5 Quidel Recent Development

11.13 Thermo Fisher Scientific

11.13.1 Thermo Fisher Scientific Company Detail

11.13.2 Thermo Fisher Scientific Business Overview

11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction

11.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.13.5 Thermo Fisher Scientific Recent Development

11.14 Trinity Biotech

11.14.1 Trinity Biotech Company Detail

11.14.2 Trinity Biotech Business Overview

11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction

11.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.14.5 Trinity Biotech Recent Development

11.15 Danaher

11.15.1 Danaher Company Detail

11.15.2 Danaher Business Overview

11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction

11.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

11.15.5 Danaher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott

Accelerate Diagnostics

Thermo Fisher Scientific

Trinity Biotech

Danaher

List of Tables

Table 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Urinary Tract Infections

Table 3. Key Players of Surgical Site Infections

Table 4. Key Players of Hospital-acquired Pneumonia

Table 5. Key Players of BloodStream Infections

Table 6. Key Players of Gastrointestinal Infections

Table 7. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2019-2024)

Table 11. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2025-2030)

Table 13. Healthcare-associated Infectious Disease Diagnostics Market Trends

Table 14. Healthcare-associated Infectious Disease Diagnostics Market Drivers

Table 15. Healthcare-associated Infectious Disease Diagnostics Market Challenges

Table 16. Healthcare-associated Infectious Disease Diagnostics Market Restraints

Table 17. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players (2019-2024)

Table 19. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2023)

Table 20. Ranking of Global Top Healthcare-associated Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service

Table 24. Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2019-2024)

Table 28. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2025-2030)

Table 30. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2019-2024)

Table 32. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2025-2030)

Table 34. North America Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 49. Abbott Company Detail

Table 50. Abbott Business Overview

Table 51. Abbott Healthcare-associated Infectious Disease Diagnostics Product

Table 52. Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 53. Abbott Recent Development

Table 54. Accelerate Diagnostics Company Detail

Table 55. Accelerate Diagnostics Business Overview

Table 56. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product

Table 57. Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 58. Accelerate Diagnostics Recent Development

Table 59. BD Company Detail

Table 60. BD Business Overview

Table 61. BD Healthcare-associated Infectious Disease Diagnostics Product

Table 62. BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 63. BD Recent Development

Table 64. bioMrieux Company Detail

Table 65. bioMrieux Business Overview

Table 66. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product

Table 67. bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 68. bioMrieux Recent Development

Table 69. Bio-Rad Company Detail

Table 70. Bio-Rad Business Overview

Table 71. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product

Table 72. Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 73. Bio-Rad Recent Development

Table 74. DiaSorin Molecular Company Detail

Table 75. DiaSorin Molecular Business Overview

Table 76. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product

Table 77. DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 78. DiaSorin Molecular Recent Development

Table 79. F. Hoffmann-La Roche Company Detail

Table 80. F. Hoffmann-La Roche Business Overview

Table 81. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product

Table 82. F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 83. F. Hoffmann-La Roche Recent Development

Table 84. Luminex Company Detail

Table 85. Luminex Business Overview

Table 86. Luminex Healthcare-associated Infectious Disease Diagnostics Product

Table 87. Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 88. Luminex Recent Development

Table 89. Meridian Bioscience Company Detail

Table 90. Meridian Bioscience Business Overview

Table 91. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product

Table 92. Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 93. Meridian Bioscience Recent Development

Table 94. OpGen Company Detail

Table 95. OpGen Business Overview

Table 96. OpGen Healthcare-associated Infectious Disease Diagnostics Product

Table 97. OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 98. OpGen Recent Development

Table 99. QIAGEN Company Detail

Table 100. QIAGEN Business Overview

Table 101. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product

Table 102. QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 103. QIAGEN Recent Development

Table 104. Quidel Company Detail

Table 105. Quidel Business Overview

Table 106. Quidel Healthcare-associated Infectious Disease Diagnostics Product

Table 107. Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 108. Quidel Recent Development

Table 109. Thermo Fisher Scientific Company Detail

Table 110. Thermo Fisher Scientific Business Overview

Table 111. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product

Table 112. Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 113. Thermo Fisher Scientific Recent Development

Table 114. Trinity Biotech Company Detail

Table 115. Trinity Biotech Business Overview

Table 116. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product

Table 117. Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 118. Trinity Biotech Recent Development

Table 119. Danaher Company Detail

Table 120. Danaher Business Overview

Table 121. Danaher Healthcare-associated Infectious Disease Diagnostics Product

Table 122. Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024) & (US$ Million)

Table 123. Danaher Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Urinary Tract Infections Features

Figure 4. Surgical Site Infections Features

Figure 5. Hospital-acquired Pneumonia Features

Figure 6. BloodStream Infections Features

Figure 7. Gastrointestinal Infections Features

Figure 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2023 VS 2030

Figure 10. Hospitals Case Studies

Figure 11. Clinics Case Studies

Figure 12. ASCs Case Studies

Figure 13. Healthcare-associated Infectious Disease Diagnostics Report Years Considered

Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region: 2023 VS 2030

Figure 17. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players in 2023

Figure 18. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2023

Figure 20. North America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2019-2030)

Figure 22. United States Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2019-2030)

Figure 26. Germany Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2019-2030)

Figure 34. China Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2019-2030)

Figure 42. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2019-2030)

Figure 46. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Abbott Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 49. Accelerate Diagnostics Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 50. BD Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 51. bioMrieux Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 52. Bio-Rad Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 53. DiaSorin Molecular Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 55. Luminex Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 56. Meridian Bioscience Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 57. OpGen Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 58. QIAGEN Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 59. Quidel Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 61. Trinity Biotech Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 62. Danaher Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions